candidate_genes,disease,celltype,y,user_question,full_query
"['TMEM62', 'CYFIP1', 'NFKBIE', 'BPGM', 'RCN1']",Sjogren syndrome,acinar cell of salivary gland,RCN1,"Which gene among TMEM62, CYFIP1, NFKBIE, BPGM, and RCN1 exhibits the highest cell-type-specific expression in salivary gland acinar cells for targeting Sjögren syndrome?","Which gene among TMEM62, CYFIP1, NFKBIE, BPGM, and RCN1 exhibits the highest cell-type-specific expression in salivary gland acinar cells for targeting Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE resource. Next, determine the overlap between these targets and the acinar cell–activated gene set from the salivary gland available in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If a single gene demonstrates significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MIF', 'NPM3', 'FAM199X', 'ZNF337', 'ANKZF1']",Sjogren syndrome,acinar cell of salivary gland,MIF,"Which gene among MIF, NPM3, FAM199X, ZNF337, and ANKZF1 displays the highest specificity for acinar cells in the salivary gland, making it the most promising target for Sjögren’s syndrome intervention?","Which gene among MIF, NPM3, FAM199X, ZNF337, and ANKZF1 displays the highest specificity for acinar cells in the salivary gland, making it the most promising target for Sjögren’s syndrome intervention? Identify the validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets are among the acinar cell–activated genes in the salivary gland as identified by PINNACLE. For the overlapping set, calculate the average embedding to serve as a reference and then compute the cosine similarity between this reference and each individual gene's embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PDK1', 'FCGRT', 'PIGL', 'ATP5MK', 'PRG4']",Sjogren syndrome,acinar cell of salivary gland,FCGRT,"Among the genes PDK1, FCGRT, PIGL, ATP5MK, and PRG4, which one exhibits the greatest cell-type specificity in salivary gland acinar cells, and thus represents the most promising candidate for targeting in Sjögren syndrome?","Among the genes PDK1, FCGRT, PIGL, ATP5MK, and PRG4, which one exhibits the greatest cell-type specificity in salivary gland acinar cells, and thus represents the most promising candidate for targeting in Sjögren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which acinar cell–activated genes in the salivary gland overlap with these targets to define the cell-type–specific targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['B3GNT2', 'ECHDC2', 'CD40', 'NEURL3', 'CDC20B']",Sjogren syndrome,acinar cell of salivary gland,CD40,"Which gene—B3GNT2, ECHDC2, CD40, NEURL3, or CDC20B—exhibits the highest specificity for salivary gland acinar cells, making it the most promising candidate for targeted intervention in Sjögren's syndrome?","Which gene—B3GNT2, ECHDC2, CD40, NEURL3, or CDC20B—exhibits the highest specificity for salivary gland acinar cells, making it the most promising candidate for targeted intervention in Sjögren's syndrome? Identify verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with PINNACLE’s acinar cell–activated genes in the salivary gland. Compute the average embedding of the overlapping set as a reference profile, then calculate the cosine similarity between this reference and each individual target gene. If one gene shows notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['H2AC19', 'CD320', 'RRP15', 'STK40', 'JAK1']",Sjogren syndrome,acinar cell of salivary gland,JAK1,"Which gene among H2AC19, CD320, RRP15, STK40, and JAK1 exhibits the highest cell-type specificity in salivary gland acinar cells for targeted intervention in Sjögren’s syndrome?","Which gene among H2AC19, CD320, RRP15, STK40, and JAK1 exhibits the highest cell-type specificity in salivary gland acinar cells for targeted intervention in Sjögren’s syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from the PINNACLE database. Next, focus on the acinar cells of the salivary gland by extracting the activated genes from PINNACLE and identify the overlap between these genes and the verified therapeutic targets, forming the cell-type–specific target set for Sjogren syndrome. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this reference vector and each individual target's embedding. If a single gene shows significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RPS18', 'HLA-DPA1', 'SH2D4A', 'SH3BGRL', 'DTX4']",Sjogren syndrome,acinar cell of salivary gland,HLA-DPA1,"Among the genes RPS18, HLA-DPA1, SH2D4A, SH3BGRL, and DTX4, which one demonstrates the highest specificity for acinar cells in the salivary gland, making it the best candidate for targeted intervention in Sjögren's syndrome?","Among the genes RPS18, HLA-DPA1, SH2D4A, SH3BGRL, and DTX4, which one demonstrates the highest specificity for acinar cells in the salivary gland, making it the best candidate for targeted intervention in Sjögren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type specific embeddings from PINNACLE. Next, intersect these targets with the acinar cell-activated genes in the salivary gland (as reported in PINNACLE) to define the cell-type specific targets. Compute the average embedding of this intersecting set to serve as a reference, and then measure the cosine similarity between this average and each individual gene’s embedding. If one gene demonstrates a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LRP3', 'TMEM65', 'TYMSOS', 'FKBP1A', 'IDH3B']",Sjogren syndrome,acinar cell of salivary gland,FKBP1A,"Which gene among LRP3, TMEM65, TYMSOS, FKBP1A, and IDH3B exhibits the highest cell-type specificity within salivary gland acinar cells, making it the most promising candidate for targeting Sjogren syndrome?","Which gene among LRP3, TMEM65, TYMSOS, FKBP1A, and IDH3B exhibits the highest cell-type specificity within salivary gland acinar cells, making it the most promising candidate for targeting Sjogren syndrome? Using verified therapeutic targets for Sjogren syndrome, retrieve their cell-type–specific embeddings from PINNACLE. Next, identify which acinar cell–activated salivary gland genes overlap with these targets to establish a set of cell-type–specific therapeutic targets. Calculate the average embedding for this overlap set, then determine the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NCAPG', 'SNX19', 'PPIA', 'EPGN', 'NAA35']",Sjogren syndrome,acinar cell of salivary gland,PPIA,"Among the genes NCAPG, SNX19, PPIA, EPGN, and NAA35, which one exhibits the highest acinar cell-specific expression in the salivary gland for targeting Sjögren's syndrome?","Among the genes NCAPG, SNX19, PPIA, EPGN, and NAA35, which one exhibits the highest acinar cell-specific expression in the salivary gland for targeting Sjögren's syndrome? Identify the validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Then, determine which of these targets overlap with genes activated in salivary gland acinar cells. Compute the average embedding for the overlapping set and calculate the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a markedly higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ITSN1', 'ENDOV', 'SMARCC2', 'UPK1B', 'ZNF534']",Sjogren syndrome,acinar cell of salivary gland,SMARCC2,"Among the genes ITSN1, ENDOV, SMARCC2, UPK1B, and ZNF534, which one exhibits the highest cell-type specificity in salivary gland acinar cells, making it the most promising candidate for targeting Sjogren syndrome?","Among the genes ITSN1, ENDOV, SMARCC2, UPK1B, and ZNF534, which one exhibits the highest cell-type specificity in salivary gland acinar cells, making it the most promising candidate for targeting Sjogren syndrome? Which verified therapeutic targets for Sjogren syndrome have established cell-type–specific embeddings in the PINNACLE database? Specifically, for acinar cells of the salivary gland, identify the subset of genes activated in these cells that overlaps with these therapeutic targets. For this overlapping set, compute the average embedding and determine the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale supporting its biological relevance."
"['RTN4IP1', 'NPFF', 'EPHX4', 'GCM1', 'HLA-DPB1']",Sjogren syndrome,acinar cell of salivary gland,HLA-DPB1,"Among RTN4IP1, NPFF, EPHX4, GCM1, and HLA-DPB1, which gene exhibits the highest specificity for acinar cells in the salivary gland, making it the most promising candidate for targeting Sjögren's syndrome?","Among RTN4IP1, NPFF, EPHX4, GCM1, and HLA-DPB1, which gene exhibits the highest specificity for acinar cells in the salivary gland, making it the most promising candidate for targeting Sjögren's syndrome? Identify the validated therapeutic targets for Sjögren's syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with acinar cell–activated genes in the salivary gland from PINNACLE. For this overlapping set, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TPRA1', 'OR52E6', 'LAD1', 'SGO2', 'CTSS']",Sjogren syndrome,acinar cell of salivary gland,CTSS,"Among the genes TPRA1, OR52E6, LAD1, SGO2, and CTSS, which exhibits the most specific expression in salivary gland acinar cells, making it the best candidate for targeting in Sjögren's syndrome research?","Among the genes TPRA1, OR52E6, LAD1, SGO2, and CTSS, which exhibits the most specific expression in salivary gland acinar cells, making it the best candidate for targeting in Sjögren's syndrome research? Identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which acinar cell–activated salivary gland genes in PINNACLE overlap with these targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference embedding and each individual target's embedding. If one gene shows a substantially higher similarity compared to the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['CNNM2', 'UPP2', 'MRPS35', 'CENPA', 'HLA-DRA']",Sjogren syndrome,acinar cell of salivary gland,HLA-DRA,"Among the following genes—CNNM2, UPP2, MRPS35, CENPA, and HLA-DRA—which one exhibits the highest cell-type specificity in salivary gland acinar cells and represents the best candidate target for Sjogren syndrome?","Among the following genes—CNNM2, UPP2, MRPS35, CENPA, and HLA-DRA—which one exhibits the highest cell-type specificity in salivary gland acinar cells and represents the best candidate target for Sjogren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in salivary gland acinar cells overlap with these targets. For the overlapping genes, compute the average embedding to serve as a reference and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance in Sjögren syndrome."
"['ABHD1', 'UPF3A', 'ZDHHC13', 'AVPR2', 'PYM1']",Sjogren syndrome,acinar cell of salivary gland,PYM1,"Which gene among ABHD1, UPF3A, ZDHHC13, AVPR2, and PYM1 shows the highest specificity in salivary gland acinar cells, making it the most promising target for Sjögren’s syndrome?","Which gene among ABHD1, UPF3A, ZDHHC13, AVPR2, and PYM1 shows the highest specificity in salivary gland acinar cells, making it the most promising target for Sjögren’s syndrome? Identify validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which acinar cell-activated genes in the salivary gland from PINNACLE overlap with these targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['MIRLET7A1', 'GTF2I', 'KIR3DL1', 'PPP4R4', 'VCPIP1']",Sjogren syndrome,acinar cell of salivary gland,GTF2I,"Which gene among MIRLET7A1, GTF2I, KIR3DL1, PPP4R4, and VCPIP1 exhibits the highest acinar cell-specific expression in the salivary gland and is most relevant for targeting Sjögren's syndrome?","Which gene among MIRLET7A1, GTF2I, KIR3DL1, PPP4R4, and VCPIP1 exhibits the highest acinar cell-specific expression in the salivary gland and is most relevant for targeting Sjögren's syndrome? Using the PINNACLE database, identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings. Next, from the acinar cell-activated gene set in the salivary gland profile available in PINNACLE, determine the genes that overlap with these therapeutic targets. Use this overlapping set as the cell-type–specific targets for Sjogren syndrome, compute their average embedding as a reference vector, and calculate the cosine similarity between this reference and the embedding for each individual gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-supported rationale for its biological significance in Sjogren syndrome."
"['IMPDH2', 'KYAT3', 'C19orf44', 'THG1L', 'FAM174A']",Sjogren syndrome,acinar cell of salivary gland,IMPDH2,"Which gene among IMPDH2, KYAT3, C19orf44, THG1L, and FAM174A exhibits the highest expression specificity in salivary gland acinar cells, making it the most promising target for interventions in Sjögren syndrome?","Which gene among IMPDH2, KYAT3, C19orf44, THG1L, and FAM174A exhibits the highest expression specificity in salivary gland acinar cells, making it the most promising target for interventions in Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific PINNACLE embeddings. Next, determine which acinar cell–activated salivary gland genes overlap with these targets, defining them as the cell-type–specific targets. Compute the average embedding for these overlapping genes and calculate the cosine similarity between this average and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HIF1A', 'NAA25', 'FRYL', 'LRG1', 'HLA-B']",Sjogren syndrome,acinar cell of salivary gland,HLA-B,"Which gene, among HIF1A, NAA25, FRYL, LRG1, and HLA-B, exhibits the highest expression specificity in salivary gland acinar cells, thereby representing the most promising single-gene target for Sjogren syndrome?","Which gene, among HIF1A, NAA25, FRYL, LRG1, and HLA-B, exhibits the highest expression specificity in salivary gland acinar cells, thereby representing the most promising single-gene target for Sjogren syndrome? Identify validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which acinar cell–activated genes in the salivary gland dataset overlap with these targets to establish a set of cell-type–specific therapeutic genes. Compute the average embedding of these overlapping genes as a reference vector, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SFTPD', 'QSOX1', 'CCDC181', 'STAT1', 'UMOD']",Sjogren syndrome,acinar cell of salivary gland,STAT1,"Which gene among SFTPD, QSOX1, CCDC181, STAT1, and UMOD exhibits the highest cell-type specificity in salivary gland acinar cells, making it the most promising candidate for targeted intervention in Sjögren syndrome?","Which gene among SFTPD, QSOX1, CCDC181, STAT1, and UMOD exhibits the highest cell-type specificity in salivary gland acinar cells, making it the most promising candidate for targeted intervention in Sjögren syndrome? For Sjogren syndrome, identify the verified therapeutic targets and extract their cell-type–specific embeddings from PINNACLE. Among genes activated in acinar cells of the salivary gland in PINNACLE, determine which overlap with these targets to define a ""cell-type–specific"" set. Compute the average embedding of this set and then calculate the cosine similarity between this average and each individual gene embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance in Sjogren syndrome."
"['IFNAR1', 'DNAJC9', 'PA2G4', 'GTF2A1L', 'HAO2']",Sjogren syndrome,acinar cell of salivary gland,IFNAR1,"Which gene—IFNAR1, DNAJC9, PA2G4, GTF2A1L, or HAO2—exhibits the highest acinar cell specificity in the salivary gland, thereby representing the most promising candidate for targeting Sjögren's syndrome?","Which gene—IFNAR1, DNAJC9, PA2G4, GTF2A1L, or HAO2—exhibits the highest acinar cell specificity in the salivary gland, thereby representing the most promising candidate for targeting Sjögren's syndrome? Identify validated therapeutic targets for Sjogren’s syndrome and extract their cell type-specific embeddings from PINNACLE. Then, determine the overlap between these targets and acinar cell-activated genes from the salivary gland in PINNACLE. Using this overlapping set as the cell-type-specific targets, compute the average embedding profile and calculate the cosine similarity between this profile and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PRKCI', 'TEX44', 'TBC1D15', 'CHRM3', 'LTA4H']",Sjogren syndrome,acinar cell of salivary gland,CHRM3,"Which gene among PRKCI, TEX44, TBC1D15, CHRM3, and LTA4H exhibits the highest cell-type specificity in salivary gland acinar cells for potential targeting in Sjögren syndrome?","Which gene among PRKCI, TEX44, TBC1D15, CHRM3, and LTA4H exhibits the highest cell-type specificity in salivary gland acinar cells for potential targeting in Sjögren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which acinar cell–activated genes in the salivary gland dataset overlap with these targets, and compute the average embedding for this overlapping set. Calculate the cosine similarity between this reference embedding and each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence‐based rationale for its biological relevance."
"['GK3P', 'MAN2A1', 'DDX6', 'ZNF624', 'SC5D']",Sjogren syndrome,acinar cell of salivary gland,DDX6,"Which gene—GK3P, MAN2A1, DDX6, ZNF624, or SC5D—demonstrates the highest specificity for salivary gland acinar cells, thereby representing the best target candidate in Sjögren’s syndrome?","Which gene—GK3P, MAN2A1, DDX6, ZNF624, or SC5D—demonstrates the highest specificity for salivary gland acinar cells, thereby representing the best target candidate in Sjögren’s syndrome? Identify experimentally verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which acinar cell–activated genes from the salivary glands overlap with these targets to define a cell-type–specific set for Sjogren syndrome. Compute the average embedding for this gene set as a reference and calculate the cosine similarity between the reference and each individual target embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HLA-B', 'TCF25', 'IGSF1', 'ADCY10P1', 'SERPINC1']",Sjogren syndrome,iga plasma cell,HLA-B,"Among HLA-B, TCF25, IGSF1, ADCY10P1, and SERPINC1, which gene demonstrates the highest cell-type specificity in IgA plasma cells for targeting Sjögren's syndrome?","Among HLA-B, TCF25, IGSF1, ADCY10P1, and SERPINC1, which gene demonstrates the highest cell-type specificity in IgA plasma cells for targeting Sjögren's syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the iga plasma cell–activated genes in PINNACLE. For the overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['INHBA', 'MAGT1', 'EIF3K', 'PSMD14', 'PPIA']",Sjogren syndrome,iga plasma cell,PPIA,"Which gene among INHBA, MAGT1, EIF3K, PSMD14, and PPIA exhibits the highest cell-type specificity in IgA-producing plasma cells, thereby representing the best candidate for targeting Sjögren syndrome?","Which gene among INHBA, MAGT1, EIF3K, PSMD14, and PPIA exhibits the highest cell-type specificity in IgA-producing plasma cells, thereby representing the best candidate for targeting Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which Iga plasma cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific set for Sjogren syndrome. Compute the average embedding of this overlapping set and then calculate the cosine similarity between the average and each individual gene embedding. If one gene shows a significantly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFB10', 'PAM', 'HSP90AA5P', 'MIF', 'BST2']",Sjogren syndrome,iga plasma cell,MIF,"Which gene among NDUFB10, PAM, HSP90AA5P, MIF, and BST2 exhibits the highest cell-type specificity in IgA plasma cells, making it the most promising candidate for targeting in Sjögren syndrome?","Which gene among NDUFB10, PAM, HSP90AA5P, MIF, and BST2 exhibits the highest cell-type specificity in IgA plasma cells, making it the most promising candidate for targeting in Sjögren syndrome? Identify the confirmed therapeutic targets for Sjögren syndrome and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of the IGA plasma cell-activated genes in PINNACLE overlap with these targets to define the cell-type-specific target set for Sjögren syndrome. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TANC2', 'FAM162A', 'CTSS', 'GDF5-AS1', 'TMEM80']",Sjogren syndrome,iga plasma cell,CTSS,"Which gene among TANC2, FAM162A, CTSS, GDF5-AS1, and TMEM80 exhibits the highest cell-type-specific expression in IgA plasma cells, thereby indicating its potential as the optimal candidate for targeting Sjögren syndrome?","Which gene among TANC2, FAM162A, CTSS, GDF5-AS1, and TMEM80 exhibits the highest cell-type-specific expression in IgA plasma cells, thereby indicating its potential as the optimal candidate for targeting Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection with IGA plasma cell-activated genes in PINNACLE to form a refined set of cell-type–specific targets. Compute the average embedding for this set and calculate the cosine similarity between this reference and each individual target. If one gene demonstrates markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['SNX33', 'ZNF285', 'TNFAIP3', 'COMMD9', 'NSA2']",Sjogren syndrome,iga plasma cell,TNFAIP3,"Among the genes SNX33, ZNF285, TNFAIP3, COMMD9, and NSA2, which one shows the highest cell-type specificity in IgA-producing plasma cells, thereby representing the optimal candidate target for therapeutic intervention in Sjögren's syndrome?","Among the genes SNX33, ZNF285, TNFAIP3, COMMD9, and NSA2, which one shows the highest cell-type specificity in IgA-producing plasma cells, thereby representing the optimal candidate target for therapeutic intervention in Sjögren's syndrome? Identify validated therapeutic targets for Sjögren syndrome and retrieve their cell type-specific embeddings from PINNACLE. Then, determine which targets overlap with the genes activated in IgA plasma cells within PINNACLE. Compute the average embedding of the overlapping set and calculate the cosine similarity between this reference and the embedding of each target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TMCO2', 'BCLAF1', 'TNFAIP3', 'UEVLD', 'IGF1']",Sjogren syndrome,iga plasma cell,TNFAIP3,"Among the candidate genes TMCO2, BCLAF1, TNFAIP3, UEVLD, and IGF1, which one exhibits the highest specificity in IgA plasma cells as a potential therapeutic target for Sjögren syndrome?","Among the candidate genes TMCO2, BCLAF1, TNFAIP3, UEVLD, and IGF1, which one exhibits the highest specificity in IgA plasma cells as a potential therapeutic target for Sjögren syndrome? Identify validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets intersect with the IGA plasma cell–activated genes from PINNACLE. For the overlapping set, compute an average embedding as a reference and calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EPCAM', 'MISP', 'MIF', 'GABARAPL3', 'ODAM']",Sjogren syndrome,iga plasma cell,MIF,"Among the genes EPCAM, MISP, MIF, GABARAPL3, and ODAM, which one exhibits the highest cell-type specificity in IgA plasma cells as a potential therapeutic target for Sjogren syndrome?","Among the genes EPCAM, MISP, MIF, GABARAPL3, and ODAM, which one exhibits the highest cell-type specificity in IgA plasma cells as a potential therapeutic target for Sjogren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in IgA plasma cells from the PINNACLE dataset. Compute the average embedding of the overlapping genes, then assess the cosine similarity between this reference embedding and each individual target’s embedding. If one gene stands out with a markedly higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPIA', 'DMPK', 'CCNK', 'GLI1', 'NOTCH1']",Sjogren syndrome,iga plasma cell,PPIA,"Which gene among PPIA, DMPK, CCNK, GLI1, and NOTCH1 demonstrates the highest cell-type specificity in IgA plasma cells, making it the most promising target for Sjögren's syndrome?","Which gene among PPIA, DMPK, CCNK, GLI1, and NOTCH1 demonstrates the highest cell-type specificity in IgA plasma cells, making it the most promising target for Sjögren's syndrome? Using the verified therapeutic targets for Sjogren syndrome, retrieve their cell type–specific embeddings from PINNACLE. Identify the targets that overlap with the IgA plasma cell–activated genes in PINNACLE to define the cell type–specific targets for Sjogren syndrome. Calculate the average embedding for this overlapping set and then determine the cosine similarity between this reference embedding and each individual target’s embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GUK1', 'CTSS', 'COX14', 'CUEDC2', 'SELP']",Sjogren syndrome,iga plasma cell,CTSS,"Which gene among GUK1, CTSS, COX14, CUEDC2, and SELP exhibits the highest cell-type specificity in IgA plasma cells for targeting Sjogren syndrome?","Which gene among GUK1, CTSS, COX14, CUEDC2, and SELP exhibits the highest cell-type specificity in IgA plasma cells for targeting Sjogren syndrome? Identify validated therapeutic targets for Sjögren's syndrome and extract their cell type-specific embeddings from PINNACLE. Next, determine which IgA plasma cell–activated genes in PINNACLE overlap with these targets, as these overlapping genes represent the cell type-specific targets for Sjögren's syndrome. Calculate the average embedding of these overlapping genes and then compute the cosine similarity between this average reference and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CRIP2', 'HLA-B', 'RSPO1', 'HNF1B', 'PAQR7']",Sjogren syndrome,iga plasma cell,HLA-B,"Among CRIP2, HLA-B, RSPO1, HNF1B, and PAQR7, which gene displays the highest cell-type specificity in IgA plasma cells for targeting Sjögren syndrome?","Among CRIP2, HLA-B, RSPO1, HNF1B, and PAQR7, which gene displays the highest cell-type specificity in IgA plasma cells for targeting Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in IgA plasma cells overlap with these targets, forming a set of cell-type–specific candidates. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SIPA1L3', 'HLF', 'VPS37D', 'CTSS', 'NPPA']",Sjogren syndrome,iga plasma cell,CTSS,"Which gene—SIPA1L3, HLF, VPS37D, CTSS, or NPPA—demonstrates the highest specificity in IgA plasma cells as a candidate target for Sjögren’s syndrome therapies?","Which gene—SIPA1L3, HLF, VPS37D, CTSS, or NPPA—demonstrates the highest specificity in IgA plasma cells as a candidate target for Sjögren’s syndrome therapies? Identify validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes associated with IgA plasma cell activation in PINNACLE overlap with these targets. For the overlapping set, compute the average embedding and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['USP4', 'CLIP2', 'TNFAIP3', 'TBCCD1', 'H6PD']",Sjogren syndrome,iga plasma cell,TNFAIP3,"Among USP4, CLIP2, TNFAIP3, TBCCD1, and H6PD, which gene exhibits the highest cell-type specificity in IgA plasma cells relevant to Sjögren's syndrome?","Among USP4, CLIP2, TNFAIP3, TBCCD1, and H6PD, which gene exhibits the highest cell-type specificity in IgA plasma cells relevant to Sjögren's syndrome? Identify verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. From these targets, determine the intersection with the set of IGA plasma cell–activated genes in PINNACLE to define the cell-type–specific targets for Sjögren syndrome. Next, calculate the average embedding of this overlapping set and compute the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['CAMK1D', 'PPIA', 'PLEKHM2', 'NPIPA1', 'TRAK1']",Sjogren syndrome,iga plasma cell,PPIA,"Among the genes CAMK1D, PPIA, PLEKHM2, NPIPA1, and TRAK1, which exhibits the highest cell-type specificity in IgA plasma cells for potential therapeutic targeting in Sjögren syndrome?","Among the genes CAMK1D, PPIA, PLEKHM2, NPIPA1, and TRAK1, which exhibits the highest cell-type specificity in IgA plasma cells for potential therapeutic targeting in Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell type-specific embeddings from the PINNACLE database. Next, determine the intersection between these targets and the IGA plasma cell-activated genes from PINNACLE to establish a set of cell type-specific targets for Sjogren syndrome. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference embedding and each individual gene's embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IFIT1', 'BICDL2', 'P2RX1', 'HLA-B', 'RPA2']",Sjogren syndrome,iga plasma cell,HLA-B,"Among the genes IFIT1, BICDL2, P2RX1, HLA-B, and RPA2, which one demonstrates the highest expression specificity in IgA plasma cells for potential targeting in Sjögren's syndrome?","Among the genes IFIT1, BICDL2, P2RX1, HLA-B, and RPA2, which one demonstrates the highest expression specificity in IgA plasma cells for potential targeting in Sjögren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the Iga plasma cell-activated genes in PINNACLE to define a set of cell-type–specific targets for Sjögren syndrome. Compute the average embedding of this set as a reference and calculate the cosine similarity between the reference and each individual target. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AADAC', 'GIPC1', 'JAGN1', 'MIF', 'MRPS2']",Sjogren syndrome,iga plasma cell,MIF,"Which gene among AADAC, GIPC1, JAGN1, MIF, and MRPS2 demonstrates the highest specificity for IgA plasma cells, making it the most promising candidate for targeted intervention in Sjögren's syndrome?","Which gene among AADAC, GIPC1, JAGN1, MIF, and MRPS2 demonstrates the highest specificity for IgA plasma cells, making it the most promising candidate for targeted intervention in Sjögren's syndrome? Identify the confirmed therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the IgA plasma cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for Sjogren syndrome. Calculate the average embedding of this overlapping set and compute the cosine similarity between this reference and each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SCRN2', 'SWI5', 'MIF', 'GREM1', 'KCNQ4']",Sjogren syndrome,iga plasma cell,MIF,"Among SCRN2, SWI5, MIF, GREM1, and KCNQ4, which gene demonstrates the highest cell-type specificity in IgA plasma cells and is therefore the most promising target for addressing Sjögren's syndrome?","Among SCRN2, SWI5, MIF, GREM1, and KCNQ4, which gene demonstrates the highest cell-type specificity in IgA plasma cells and is therefore the most promising target for addressing Sjögren's syndrome? Identify the validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the IGA plasma cell–activated genes in PINNACLE overlap with these targets, forming the cell-type–specific target set. Compute the average embedding for this set and then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TMEM159', 'OR7C2', 'CTSS', 'MXD3', 'GCNT4']",Sjogren syndrome,iga plasma cell,CTSS,"Which gene among TMEM159, OR7C2, CTSS, MXD3, and GCNT4 exhibits the highest specificity in IgA plasma cells, making it the best candidate target for Sjögren’s syndrome intervention?","Which gene among TMEM159, OR7C2, CTSS, MXD3, and GCNT4 exhibits the highest specificity in IgA plasma cells, making it the best candidate target for Sjögren’s syndrome intervention? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the iga plasma cell-activated genes in PINNACLE overlap with these targets, and compute the average embedding for this overlapping set. Then, calculate the cosine similarity between this average embedding and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['NFATC2IP', 'BCKDHB', 'TNFAIP3', 'CEPT1', 'RAB5C']",Sjogren syndrome,iga plasma cell,TNFAIP3,"Among NFATC2IP, BCKDHB, TNFAIP3, CEPT1, and RAB5C, which gene exhibits the highest cell-type specificity in IgA plasma cells relevant to Sjögren syndrome, thereby representing the most promising target for further study?","Among NFATC2IP, BCKDHB, TNFAIP3, CEPT1, and RAB5C, which gene exhibits the highest cell-type specificity in IgA plasma cells relevant to Sjögren syndrome, thereby representing the most promising target for further study? Identify verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the IGA plasma cell-activated genes in PINNACLE, defining this intersection as the cell-type–specific targets for Sjogren syndrome. Calculate the average embedding of these overlapping targets and then compute the cosine similarity between the average embedding and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF559-ZNF177', 'HLA-B', 'STARD10', 'TAC1', 'MON1B']",Sjogren syndrome,iga plasma cell,HLA-B,"Among the genes ZNF559-ZNF177, HLA-B, STARD10, TAC1, and MON1B, which one demonstrates the highest cell-type specificity in IgA plasma cells, making it the most promising target for therapeutic strategies in Sjögren syndrome?","Among the genes ZNF559-ZNF177, HLA-B, STARD10, TAC1, and MON1B, which one demonstrates the highest cell-type specificity in IgA plasma cells, making it the most promising target for therapeutic strategies in Sjögren syndrome? For Sjogren syndrome, identify all verified therapeutic targets and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the IGA plasma cell-activated genes in PINNACLE to define the cell-type–specific targets for the syndrome. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CRTAC1', 'SS18L2', 'PPIA', 'GK3P', 'CLNS1A']",Sjogren syndrome,iga plasma cell,PPIA,"Which gene among CRTAC1, SS18L2, PPIA, GK3P, and CLNS1A exhibits the highest specificity in IgA-expressing plasma cells, making it a prime candidate for targeting Sjögren syndrome?","Which gene among CRTAC1, SS18L2, PPIA, GK3P, and CLNS1A exhibits the highest specificity in IgA-expressing plasma cells, making it a prime candidate for targeting Sjögren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from the PINNACLE dataset. Determine which of these targets overlap with genes activated in IGA plasma cells. For the overlapping gene set, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['IFNAR1', 'PARP4', 'BRI3', 'GSTM5', 'MTA3']",Sjogren syndrome,endothelial cell,IFNAR1,"Which gene among IFNAR1, PARP4, BRI3, GSTM5, and MTA3 exhibits the highest specificity for endothelial cells in the context of targeting Sjögren's syndrome?","Which gene among IFNAR1, PARP4, BRI3, GSTM5, and MTA3 exhibits the highest specificity for endothelial cells in the context of targeting Sjögren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the endothelial cell–activated genes in PINNACLE, and compute the average embedding of the overlapping set. Next, calculate the cosine similarity between this average embedding and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based explanation of its biological relevance."
"['GTF2I', 'GGNBP2', 'JOSD2', 'TEX44', 'PSMB4']",Sjogren syndrome,endothelial cell,GTF2I,"Among the genes GTF2I, GGNBP2, JOSD2, TEX44, and PSMB4, which one exhibits the highest endothelial cell–specific expression for targeting Sjögren’s syndrome?","Among the genes GTF2I, GGNBP2, JOSD2, TEX44, and PSMB4, which one exhibits the highest endothelial cell–specific expression for targeting Sjögren’s syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets to define a subset of cell-type–specific targets for Sjogren syndrome. Calculate the average embedding for this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['DGCR8', 'NRG2', 'DDX6', 'WNT11', 'ARHGEF16']",Sjogren syndrome,endothelial cell,DDX6,"Which gene among DGCR8, NRG2, DDX6, WNT11, and ARHGEF16 exhibits the highest specificity for endothelial cells, making it the most promising candidate for targeting in Sjögren syndrome?","Which gene among DGCR8, NRG2, DDX6, WNT11, and ARHGEF16 exhibits the highest specificity for endothelial cells, making it the most promising candidate for targeting in Sjögren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with genes activated in endothelial cells in PINNACLE, and compute the average embedding for this overlapping set. Then calculate the cosine similarity between this average embedding and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise evidence-based rationale for its biological significance."
"['TRIM7', 'HLA-DPA1', 'NEK9', 'ACTL8', 'FZD6']",Sjogren syndrome,endothelial cell,HLA-DPA1,"Among the genes TRIM7, HLA-DPA1, NEK9, ACTL8, and FZD6, which one exhibits the highest specificity of expression in endothelial cells pertinent to developing targeted therapies for Sjögren syndrome?","Among the genes TRIM7, HLA-DPA1, NEK9, ACTL8, and FZD6, which one exhibits the highest specificity of expression in endothelial cells pertinent to developing targeted therapies for Sjögren syndrome? Identify verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and endothelial cell-activated genes in PINNACLE. Using this overlapping set as the cell-type–specific targets for Sjögren syndrome, compute their average embedding as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['IL13', 'RBM8A', 'RCN1', 'ZNF500', 'ACTR5']",Sjogren syndrome,endothelial cell,RCN1,"Which gene among IL13, RBM8A, RCN1, ZNF500, and ACTR5 demonstrates the highest endothelial cell-specific expression for potential targeting in Sjögren's syndrome?","Which gene among IL13, RBM8A, RCN1, ZNF500, and ACTR5 demonstrates the highest endothelial cell-specific expression for potential targeting in Sjögren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell type–specific embeddings from the PINNACLE database. Next, determine which endothelial cell–activated genes in PINNACLE overlap with these targets and compute their average embedding to serve as a reference profile. Then, calculate the cosine similarity between this reference and the embedding of each overlapping target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NPB', 'NLRP10', 'DEFA1', 'NR3C1', 'PTGES3']",Sjogren syndrome,endothelial cell,NR3C1,"Among the genes NPB, NLRP10, DEFA1, NR3C1, and PTGES3, which one exhibits the highest cell-type specificity in endothelial cells, making it the most promising target for interventions in Sjögren’s syndrome?","Among the genes NPB, NLRP10, DEFA1, NR3C1, and PTGES3, which one exhibits the highest cell-type specificity in endothelial cells, making it the most promising target for interventions in Sjögren’s syndrome? Identify validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, from the PINNACLE dataset, determine which endothelial cell–activated genes overlap with these targets. Compute the average embedding of the overlapping set as a reference, then calculate the cosine similarity between this reference and each individual gene. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['PYGB', 'PFKFB4', 'VPS35', 'SMU1', 'BAZ2A']",Sjogren syndrome,endothelial cell,BAZ2A,"Among the genes PYGB, PFKFB4, VPS35, SMU1, and BAZ2A, which shows the highest specificity for endothelial cells in relation to targeting Sjögren syndrome?","Among the genes PYGB, PFKFB4, VPS35, SMU1, and BAZ2A, which shows the highest specificity for endothelial cells in relation to targeting Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the endothelial cell-activated genes in PINNACLE to define the cell-type-specific targets for the disease. Compute the average embedding of this overlap set as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits significantly higher similarity than the rest, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GRM1', 'NLRP12', 'SWAP70', 'SGTA', 'JAK1']",Sjogren syndrome,endothelial cell,JAK1,"Among GRM1, NLRP12, SWAP70, SGTA, and JAK1, which gene demonstrates the highest endothelial cell-type specificity relevant for targeting Sjogren's syndrome?","Among GRM1, NLRP12, SWAP70, SGTA, and JAK1, which gene demonstrates the highest endothelial cell-type specificity relevant for targeting Sjogren's syndrome? Identify validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the subset of these targets that overlaps with endothelial cell–activated genes in PINNACLE. For this overlapping set, compute the average embedding and calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['PPIA', 'RPF1', 'C11orf54', 'MILR1', 'INSYN2A']",Sjogren syndrome,endothelial cell,PPIA,"Which gene among PPIA, RPF1, C11orf54, MILR1, and INSYN2A exhibits the highest specificity to endothelial cells for potential targeting in Sjögren's syndrome?","Which gene among PPIA, RPF1, C11orf54, MILR1, and INSYN2A exhibits the highest specificity to endothelial cells for potential targeting in Sjögren's syndrome? Identify validated therapeutic targets for Sjögren's syndrome and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the endothelial cell–activated genes in PINNACLE, defining the cell-type–specific targets for the syndrome. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this reference profile and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['RCN1', 'TRMT2A', 'PEX13', 'ARHGAP24', 'OTP']",Sjogren syndrome,endothelial cell,RCN1,"Which gene among RCN1, TRMT2A, PEX13, ARHGAP24, and OTP exhibits the most specific expression in endothelial cells, making it the prime candidate for targeted studies in Sjogren syndrome?","Which gene among RCN1, TRMT2A, PEX13, ARHGAP24, and OTP exhibits the most specific expression in endothelial cells, making it the prime candidate for targeted studies in Sjogren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets, and compute the average embedding of this overlapping gene set. Then, calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['BAZ2A', 'NRBF2', 'TBC1D3G', 'LAS1L', 'SPATA3']",Sjogren syndrome,endothelial cell,BAZ2A,"Which gene among BAZ2A, NRBF2, TBC1D3G, LAS1L, and SPATA3 demonstrates the highest specificity in endothelial cells, thereby emerging as the most promising target for interventions in Sjögren's syndrome?","Which gene among BAZ2A, NRBF2, TBC1D3G, LAS1L, and SPATA3 demonstrates the highest specificity in endothelial cells, thereby emerging as the most promising target for interventions in Sjögren's syndrome? Identify the validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, identify the subset of endothelial cell-activation genes from PINNACLE that overlap with these targets, forming the cell-type–specific candidate set. Compute the average embedding of these candidates as a reference, then calculate the cosine similarity between this reference and each individual candidate gene. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a succinct, evidence-based rationale for its biological relevance."
"['PPIA', 'RASGRP2', 'PGAP2', 'MVB12B', 'CDH19']",Sjogren syndrome,endothelial cell,PPIA,"Which gene among PPIA, RASGRP2, PGAP2, MVB12B, and CDH19 demonstrates the highest specificity in endothelial cells, making it the strongest candidate for targeted intervention in Sjögren's syndrome?","Which gene among PPIA, RASGRP2, PGAP2, MVB12B, and CDH19 demonstrates the highest specificity in endothelial cells, making it the strongest candidate for targeted intervention in Sjögren's syndrome? Identify all validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which endothelial cell–activated genes in PINNACLE overlap with these targets to define the relevant cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['POLE2', 'ZNF275', 'UGT2B7', 'RPS6', 'DDX6']",Sjogren syndrome,endothelial cell,DDX6,"Which gene among POLE2, ZNF275, UGT2B7, RPS6, and DDX6 exhibits the highest specificity for endothelial cells, making it the most promising candidate for targeting in Sjögren syndrome?","Which gene among POLE2, ZNF275, UGT2B7, RPS6, and DDX6 exhibits the highest specificity for endothelial cells, making it the most promising candidate for targeting in Sjögren syndrome? Identify the confirmed therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the endothelial cell-activated genes in PINNACLE. Compute the average embedding for the overlapping genes, calculate the cosine similarity between this average embedding and each individual gene’s embedding, and nominate the gene with a markedly higher similarity as the top candidate—providing a concise, evidence-based rationale for its biological relevance."
"['JAK1', 'UNC50', 'DERL2', 'SMIM1', 'MAGED1']",Sjogren syndrome,endothelial cell,JAK1,"Among the genes JAK1, UNC50, DERL2, SMIM1, and MAGED1, which one exhibits the highest specificity for endothelial cells in the context of therapeutic targeting for Sjogren’s syndrome?","Among the genes JAK1, UNC50, DERL2, SMIM1, and MAGED1, which one exhibits the highest specificity for endothelial cells in the context of therapeutic targeting for Sjogren’s syndrome? Using validated therapeutic targets for Sjogren syndrome, retrieve their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and endothelial cell-activated genes from PINNACLE to establish a set of cell-type–specific targets. Compute the average embedding of this overlapped set as a reference, and calculate the cosine similarity between this reference and each individual target. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLITRK5', 'YIPF6', 'NDUFB1', 'GDF5-AS1', 'GTF2I']",Sjogren syndrome,endothelial cell,GTF2I,"Among the genes SLITRK5, YIPF6, NDUFB1, GDF5‐AS1, and GTF2I, which gene exhibits the most endothelial cell–specific expression relevant to targeting Sjögren syndrome?","Among the genes SLITRK5, YIPF6, NDUFB1, GDF5‐AS1, and GTF2I, which gene exhibits the most endothelial cell–specific expression relevant to targeting Sjögren syndrome? Using PINNACLE, retrieve cell-type–specific embeddings for all validated therapeutic targets of Sjögren syndrome. Then, identify which endothelial cell–activated genes overlap with these targets. Compute the average embedding for this overlapping set and determine the cosine similarity between the average and each individual target embedding. If one gene shows a notably higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based explanation of its biological relevance."
"['SLC30A1', 'SERPINA5', 'ETS2', 'NKX3-1', 'NR3C1']",Sjogren syndrome,endothelial cell,NR3C1,"Among the genes SLC30A1, SERPINA5, ETS2, NKX3-1, and NR3C1, which one exhibits the highest endothelial cell-specific expression relevant to targeting Sjögren syndrome?","Among the genes SLC30A1, SERPINA5, ETS2, NKX3-1, and NR3C1, which one exhibits the highest endothelial cell-specific expression relevant to targeting Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the endothelial cell–activated genes in PINNACLE that overlap with these targets, defining the cell-type–specific target set. Calculate the average embedding for this set, then compute the cosine similarity between this average and each individual gene embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['HLA-DPA1', 'KRT6B', 'NDUFA1', 'UBXN11', 'TIMM10']",Sjogren syndrome,endothelial cell,HLA-DPA1,"Which gene among HLA-DPA1, KRT6B, NDUFA1, UBXN11, and TIMM10 exhibits the highest endothelial cell specificity for targeted intervention in Sjögren syndrome?","Which gene among HLA-DPA1, KRT6B, NDUFA1, UBXN11, and TIMM10 exhibits the highest endothelial cell specificity for targeted intervention in Sjögren syndrome? Using the list of verified therapeutic targets for Sjogren syndrome, retrieve their cell-type–specific embeddings from the PINNACLE database. Next, identify which of the endothelial cell-activated genes in PINNACLE overlap with these therapeutic targets for Sjogren syndrome. Compute the average embedding of the overlapping set to serve as a reference and calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FABP7', 'IFNAR1', 'LCP2', 'FBXO7', 'TPP1']",Sjogren syndrome,endothelial cell,IFNAR1,"Among the genes FABP7, IFNAR1, LCP2, FBXO7, and TPP1, which exhibits the highest endothelial cell specificity and represents the most promising target for therapeutic intervention in Sjogren syndrome?","Among the genes FABP7, IFNAR1, LCP2, FBXO7, and TPP1, which exhibits the highest endothelial cell specificity and represents the most promising target for therapeutic intervention in Sjogren syndrome? Identify all verified therapeutic targets for Sjögren syndrome and retrieve their corresponding cell-type-specific embeddings from PINNACLE. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets, thereby defining a set of cell-type-specific targets related to Sjögren syndrome. Compute the average embedding of this overlapping set to serve as a reference, and calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CKS1B', 'IFNAR1', 'PHRF1', 'GRWD1', 'SAMD13']",Sjogren syndrome,endothelial cell,IFNAR1,"Among the genes CKS1B, IFNAR1, PHRF1, GRWD1, and SAMD13, which exhibits the highest endothelial cell-specific expression and is therefore the most promising target for interventions in Sjogren's syndrome?","Among the genes CKS1B, IFNAR1, PHRF1, GRWD1, and SAMD13, which exhibits the highest endothelial cell-specific expression and is therefore the most promising target for interventions in Sjogren's syndrome? Identify experimentally validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the endothelial cell-activated genes in PINNACLE, thereby defining the cell-type–specific targets for Sjogren syndrome. Calculate the average embedding for these overlapping genes and compute the cosine similarity between this averaged embedding and each individual target's embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DBH', 'PIH1D1', 'MIOS', 'CYRIB', 'BAZ2A']",Sjogren syndrome,endothelial cell,BAZ2A,"Which gene among DBH, PIH1D1, MIOS, CYRIB, and BAZ2A exhibits the most specific expression in endothelial cells as a potential target for Sjögren syndrome?","Which gene among DBH, PIH1D1, MIOS, CYRIB, and BAZ2A exhibits the most specific expression in endothelial cells as a potential target for Sjögren syndrome? Identify verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with endothelial cell-activated genes in PINNACLE. Compute the average embedding for the overlapping set and calculate the cosine similarity between this average and the embedding of each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CHCHD6', 'KAT7', 'IMPDH2', 'NGDN', 'ZC3H12C']",Sjogren syndrome,duct epithelial cell,IMPDH2,"Among CHCHD6, KAT7, IMPDH2, NGDN, and ZC3H12C, which gene exhibits the highest cell-type specificity in duct epithelial cells for targeted intervention in Sjögren’s syndrome?","Among CHCHD6, KAT7, IMPDH2, NGDN, and ZC3H12C, which gene exhibits the highest cell-type specificity in duct epithelial cells for targeted intervention in Sjögren’s syndrome? Identify validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the duct epithelial cell-activated genes in PINNACLE. For the overlapping genes, compute an average embedding vector as a reference, then calculate the cosine similarity between this reference and each individual gene. Finally, if one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPIA', 'ARTN', 'ZNF852', 'SERTAD1', 'ERGIC2']",Sjogren syndrome,duct epithelial cell,PPIA,"Among the genes PPIA, ARTN, ZNF852, SERTAD1, and ERGIC2, which one demonstrates the greatest cell-type specificity in duct epithelial cells, making it the most promising candidate for targeting Sjögren's syndrome?","Among the genes PPIA, ARTN, ZNF852, SERTAD1, and ERGIC2, which one demonstrates the greatest cell-type specificity in duct epithelial cells, making it the most promising candidate for targeting Sjögren's syndrome? Identify validated therapeutic targets for Sjögren syndrome and extract their cell-type-specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in duct epithelial cells in PINNACLE. For the overlapping set, compute the mean embedding vector and calculate the cosine similarity between this reference and each individual target. If one gene exhibits notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['PPP2R2C', 'HLA-B', 'TRMT6', 'ZBTB33', 'XCL1']",Sjogren syndrome,duct epithelial cell,HLA-B,"Which gene—PPP2R2C, HLA-B, TRMT6, ZBTB33, or XCL1—exhibits the highest cell-type specificity in ductal epithelial cells for targeting Sjögren syndrome?","Which gene—PPP2R2C, HLA-B, TRMT6, ZBTB33, or XCL1—exhibits the highest cell-type specificity in ductal epithelial cells for targeting Sjögren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and retrieve their corresponding cell-type–specific embeddings from the PINNACLE database. From the duct epithelial cells activated in this condition, determine the overlapping genes with these targets to define a cell-specific target set. Compute the average embedding of this set and then calculate the cosine similarity between this average and each individual gene's embedding. If one gene exhibits significantly higher similarity, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['EID3', 'ZFHX2', 'HLA-DRA', 'H4C7', 'PLRG1']",Sjogren syndrome,duct epithelial cell,HLA-DRA,"Among the candidate genes EID3, ZFHX2, HLA-DRA, H4C7, and PLRG1, which one exhibits the greatest specificity for ductal epithelial cells, making it the most promising target for studies related to Sjögren's syndrome?","Among the candidate genes EID3, ZFHX2, HLA-DRA, H4C7, and PLRG1, which one exhibits the greatest specificity for ductal epithelial cells, making it the most promising target for studies related to Sjögren's syndrome? Using verified therapeutic targets for Sjogren syndrome, retrieve their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and the duct epithelial cell–activated genes in PINNACLE to define the cell-type–specific targets for Sjogren syndrome. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['GP2', 'CENPQ', 'MT-CO3', 'HLA-DPB1', 'PRIM1']",Sjogren syndrome,duct epithelial cell,HLA-DPB1,"Which gene among GP2, CENPQ, MT-CO3, HLA-DPB1, and PRIM1 demonstrates the highest specificity in duct epithelial cells, making it the most suitable target for Sjogren syndrome research?","Which gene among GP2, CENPQ, MT-CO3, HLA-DPB1, and PRIM1 demonstrates the highest specificity in duct epithelial cells, making it the most suitable target for Sjogren syndrome research? Identify validated therapeutic targets for Sjögren's syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes activated in duct epithelial cells overlap with these targets, forming the cell-type–specific target set. Compute the average embedding of this set to serve as a reference, then calculate the cosine similarity between the reference and each individual gene embedding. Finally, if one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SENP3', 'RAB9A', 'TUBB6', 'SPA17', 'FCGRT']",Sjogren syndrome,duct epithelial cell,FCGRT,"Which gene among SENP3, RAB9A, TUBB6, SPA17, and FCGRT demonstrates the highest cell-type specificity in duct epithelial cells for targeting Sjögren’s syndrome?","Which gene among SENP3, RAB9A, TUBB6, SPA17, and FCGRT demonstrates the highest cell-type specificity in duct epithelial cells for targeting Sjögren’s syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlapping genes between these targets and the duct epithelial cell-activated genes in PINNACLE. Compute the average embedding of the overlapping set and calculate the cosine similarity between this average and each individual gene embedding. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['THAP11', 'C5AR2', 'RTF1', 'PPIA', 'C11orf16']",Sjogren syndrome,duct epithelial cell,PPIA,"Among the genes THAP11, C5AR2, RTF1, PPIA, and C11orf16, which one demonstrates the highest cell-type specificity in ductal epithelial cells relevant to Sjögren syndrome?","Among the genes THAP11, C5AR2, RTF1, PPIA, and C11orf16, which one demonstrates the highest cell-type specificity in ductal epithelial cells relevant to Sjögren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the genes activated in duct epithelial cells within PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for Sjögren syndrome. Compute the average embedding of these overlapping genes to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene demonstrates a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['FST', 'HLA-DRA', 'ARID1B', 'SAMD11', 'MED11']",Sjogren syndrome,duct epithelial cell,HLA-DRA,"Which gene among FST, HLA-DRA, ARID1B, SAMD11, and MED11 shows the most specific expression in duct epithelial cells for targeting Sjögren's syndrome?","Which gene among FST, HLA-DRA, ARID1B, SAMD11, and MED11 shows the most specific expression in duct epithelial cells for targeting Sjögren's syndrome? Identify verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which duct epithelial cell–activated genes in PINNACLE intersect with these targets to define a set of cell-type specific targets for the syndrome. Compute the average embedding of this set, then calculate the cosine similarity between this reference and each individual embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ARCN1', 'ITGB2', 'HLA-B', 'MMS22L', 'NCALD']",Sjogren syndrome,duct epithelial cell,HLA-B,"Which gene among ARCN1, ITGB2, HLA-B, MMS22L, and NCALD exhibits the highest cell-type specificity in duct epithelial cells, making it a prime candidate for targeting Sjögren syndrome?","Which gene among ARCN1, ITGB2, HLA-B, MMS22L, and NCALD exhibits the highest cell-type specificity in duct epithelial cells, making it a prime candidate for targeting Sjögren syndrome? Identify the verified therapeutic targets for primary Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with duct epithelial cell–activated genes, and compute the average embedding of this overlapping set as a reference. Then, calculate the cosine similarity between this reference and the embedding of each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ASB1', 'SPOUT1', 'FAM180B', 'FCGRT', 'ALCAM']",Sjogren syndrome,duct epithelial cell,FCGRT,"Which gene among ASB1, SPOUT1, FAM180B, FCGRT, and ALCAM demonstrates the highest specificity for ductal epithelial cells, making it the most promising target for Sjögren's syndrome research?","Which gene among ASB1, SPOUT1, FAM180B, FCGRT, and ALCAM demonstrates the highest specificity for ductal epithelial cells, making it the most promising target for Sjögren's syndrome research? Identify the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the duct epithelial cell-activated genes from PINNACLE to define the cell-type–specific targets for Sjogren syndrome. Compute the average embedding of this overlap set, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale supporting its biological relevance."
"['MT-CYB', 'AUTS2', 'RAB1A', 'ALG11', 'HLA-DPB1']",Sjogren syndrome,duct epithelial cell,HLA-DPB1,"Which gene among MT-CYB, AUTS2, RAB1A, ALG11, and HLA-DPB1 exhibits the highest expression specificity in ductal epithelial cells, making it the most promising candidate for targeted intervention in Sjögren's syndrome?","Which gene among MT-CYB, AUTS2, RAB1A, ALG11, and HLA-DPB1 exhibits the highest expression specificity in ductal epithelial cells, making it the most promising candidate for targeted intervention in Sjögren's syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the duct epithelial cell–activated genes represented in PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding for this set and then compute the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ETV6', 'KDM6A', 'LNPEP', 'IMPDH2', 'GPRIN2']",Sjogren syndrome,duct epithelial cell,IMPDH2,"Among ETV6, KDM6A, LNPEP, IMPDH2, and GPRIN2, which gene exhibits the highest cell-type specificity in duct epithelial cells as a potential target for Sjögren syndrome?","Among ETV6, KDM6A, LNPEP, IMPDH2, and GPRIN2, which gene exhibits the highest cell-type specificity in duct epithelial cells as a potential target for Sjögren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in duct epithelial cells to define a set of cell-type–specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TMEM135', 'PPIA', 'TNFAIP1', 'DGKI', 'NR2E3']",Sjogren syndrome,duct epithelial cell,PPIA,"Which gene among TMEM135, PPIA, TNFAIP1, DGKI, and NR2E3 exhibits the highest cell-type specificity in duct epithelial cells for applications related to Sjogren syndrome?","Which gene among TMEM135, PPIA, TNFAIP1, DGKI, and NR2E3 exhibits the highest cell-type specificity in duct epithelial cells for applications related to Sjogren syndrome? Identify the validated therapeutic targets for Sjögren's syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the duct epithelial cell-activated genes in PINNACLE, as this overlap represents potential cell-type–specific targets. Compute the average embedding from this overlapping set as a reference and calculate the cosine similarity between the reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FAM120C', 'IMPDH2', 'GRAMD1A', 'RASAL3', 'LBX2']",Sjogren syndrome,duct epithelial cell,IMPDH2,"Among the genes FAM120C, IMPDH2, GRAMD1A, RASAL3, and LBX2, which one exhibits the highest specificity to duct epithelial cells, making it the most promising candidate for targeting in Sjögren syndrome?","Among the genes FAM120C, IMPDH2, GRAMD1A, RASAL3, and LBX2, which one exhibits the highest specificity to duct epithelial cells, making it the most promising candidate for targeting in Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and extract their corresponding cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the genes activated in duct epithelial cells. For the overlapping genes, compute the average embedding and calculate the cosine similarity between this average and each individual target embedding. If a single gene exhibits a markedly higher similarity compared to the others, nominate that gene as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KIAA0895L', 'ZNF268', 'PHF5A', 'GCN1', 'HLA-DPB1']",Sjogren syndrome,duct epithelial cell,HLA-DPB1,"Which gene among KIAA0895L, ZNF268, PHF5A, GCN1, and HLA-DPB1 exhibits the highest specificity of expression in duct epithelial cells in the context of Sjögren's syndrome, making it the optimal candidate for targeted studies?","Which gene among KIAA0895L, ZNF268, PHF5A, GCN1, and HLA-DPB1 exhibits the highest specificity of expression in duct epithelial cells in the context of Sjögren's syndrome, making it the optimal candidate for targeted studies? Identify the validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which duct epithelial cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets. Compute the average embedding for this set and calculate the cosine similarity between this average and the embedding of each target gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['H3-3A', 'CCNY', 'MRPL40', 'HLA-DRA', 'MYH1']",Sjogren syndrome,duct epithelial cell,HLA-DRA,"Among H3-3A, CCNY, MRPL40, HLA-DRA, and MYH1, which gene exhibits the most specific expression in duct epithelial cells for targeting Sjögren’s syndrome?","Among H3-3A, CCNY, MRPL40, HLA-DRA, and MYH1, which gene exhibits the most specific expression in duct epithelial cells for targeting Sjögren’s syndrome? Identify and validate therapeutic targets for Sjögren syndrome by retrieving their cell-type-specific embeddings from PINNACLE. Next, determine which genes activated in duct epithelial cells from PINNACLE overlap with these targets to define a set of cell-type-specific targets for Sjögren syndrome. Compute the average embedding of this gene set, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale supporting its biological relevance."
"['LTF', 'HLA-B', 'CAPN15', 'TMEM167A', 'APOL6']",Sjogren syndrome,duct epithelial cell,HLA-B,"Which gene among LTF, HLA-B, CAPN15, TMEM167A, and APOL6 demonstrates the highest specificity for duct epithelial cells in the context of targeting Sjogren syndrome?","Which gene among LTF, HLA-B, CAPN15, TMEM167A, and APOL6 demonstrates the highest specificity for duct epithelial cells in the context of targeting Sjogren syndrome? Identify well-validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the duct epithelial cell-activated genes in PINNACLE. Using the overlapping set as the cell-type–specific targets for Sjögren syndrome, compute their average embedding vector and then calculate the cosine similarity between this reference vector and each individual gene embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ABCC1', 'FCGRT', 'DDX56', 'PLS3', 'APTX']",Sjogren syndrome,duct epithelial cell,FCGRT,"Among the genes ABCC1, FCGRT, DDX56, PLS3, and APTX, which shows the highest cell-type specificity in ductal epithelial cells for targeting interventions in Sjogren syndrome?","Among the genes ABCC1, FCGRT, DDX56, PLS3, and APTX, which shows the highest cell-type specificity in ductal epithelial cells for targeting interventions in Sjogren syndrome? Identify all validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlapping genes between these targets and the duct epithelial cell–activated genes in PINNACLE, as these represent the cell-type–specific targets for Sjögren syndrome. Compute the average embedding for this overlapping gene set, then calculate the cosine similarity between this average and each individual embedding. Finally, if one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MUC1', 'HLA-B', 'TMOD3', 'CKMT1A', 'ADGRE2']",Sjogren syndrome,duct epithelial cell,HLA-B,"Which gene among MUC1, HLA-B, TMOD3, CKMT1A, and ADGRE2 shows the most specific expression in duct epithelial cells, thereby representing the best target for Sjogren's syndrome research?","Which gene among MUC1, HLA-B, TMOD3, CKMT1A, and ADGRE2 shows the most specific expression in duct epithelial cells, thereby representing the best target for Sjogren's syndrome research? Identify the verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these intersect with the genes activated in duct epithelial cells, and compute the average embedding for this overlapping set as a reference. Then, calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['H3C15', 'HLA-DPB1', 'GFER', 'RPLP2', 'SRSF3']",Sjogren syndrome,duct epithelial cell,HLA-DPB1,"Among the following genes—H3C15, HLA-DPB1, GFER, RPLP2, and SRSF3—which one exhibits the highest specificity for duct epithelial cells, thereby representing the most promising target for therapeutic intervention in Sjogren's syndrome?","Among the following genes—H3C15, HLA-DPB1, GFER, RPLP2, and SRSF3—which one exhibits the highest specificity for duct epithelial cells, thereby representing the most promising target for therapeutic intervention in Sjogren's syndrome? Identify the validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the duct epithelial cell-activated genes in PINNACLE to define a set of cell-type–specific targets for Sjögren syndrome. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PRPF38A', 'HLA-B', 'PDE6A', 'ZNF662', 'ZNF420']",Sjogren syndrome,myoepithelial cell,HLA-B,"Which gene—PRPF38A, HLA-B, PDE6A, ZNF662, or ZNF420—demonstrates the highest specificity for myoepithelial cells, making it the most promising candidate for targeting Sjogren syndrome?","Which gene—PRPF38A, HLA-B, PDE6A, ZNF662, or ZNF420—demonstrates the highest specificity for myoepithelial cells, making it the most promising candidate for targeting Sjogren syndrome? Identify the validated therapeutic targets for Sjogren syndrome that have corresponding cell‐type specific embeddings in PINNACLE. From these, select those that overlap with myoepithelial cell-activated genes in the dataset, and compute the average embedding for this overlapping set. Then, calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['FKBP1A', 'MARCHF7', 'DLG3', 'SLITRK1', 'SNX7']",Sjogren syndrome,myoepithelial cell,FKBP1A,"Which gene—FKBP1A, MARCHF7, DLG3, SLITRK1, or SNX7—exhibits the highest specificity for myoepithelial cells, making it the most promising candidate for targeting Sjögren’s syndrome?","Which gene—FKBP1A, MARCHF7, DLG3, SLITRK1, or SNX7—exhibits the highest specificity for myoepithelial cells, making it the most promising candidate for targeting Sjögren’s syndrome? Identify validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the myoepithelial cell-activated gene set in PINNACLE, yielding a refined list of cell-type–specific targets. Compute the average embedding of this overlapping set, then assess the cosine similarity between this average and the embedding of each individual target. If one gene displays significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HSD17B12', 'SUMO2', 'PPIA', 'PCDHA2', 'ARID1A']",Sjogren syndrome,myoepithelial cell,PPIA,"Which gene among HSD17B12, SUMO2, PPIA, PCDHA2, and ARID1A demonstrates the highest specificity for myoepithelial cells in the context of Sjogren syndrome?","Which gene among HSD17B12, SUMO2, PPIA, PCDHA2, and ARID1A demonstrates the highest specificity for myoepithelial cells in the context of Sjogren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the myoepithelial cell–activated genes in PINNACLE. Calculate the average embedding for this overlapping set to serve as a reference, and then compute the cosine similarity between this reference and each individual target gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SPON2', 'TMUB2', 'ATG16L1', 'MIF', 'DENND2D']",Sjogren syndrome,myoepithelial cell,MIF,"Among the genes SPON2, TMUB2, ATG16L1, MIF, and DENND2D, which one exhibits the highest specificity to myoepithelial cells, thereby representing the most promising target for interventions in Sjögren's syndrome?","Among the genes SPON2, TMUB2, ATG16L1, MIF, and DENND2D, which one exhibits the highest specificity to myoepithelial cells, thereby representing the most promising target for interventions in Sjögren's syndrome? Identify the validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with myoepithelial cell-activated genes in PINNACLE, defining this intersection as the cell-type–specific targets for the syndrome. Compute the average embedding for these overlapping targets, then calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['STRAP', 'JAK1', 'B3GAT3', 'CAPN10', 'M1AP']",Sjogren syndrome,myoepithelial cell,JAK1,"Among the genes STRAP, JAK1, B3GAT3, CAPN10, and M1AP, which exhibits the most specific expression in myoepithelial cells, making it the optimal candidate for targeted intervention in Sjögren syndrome?","Among the genes STRAP, JAK1, B3GAT3, CAPN10, and M1AP, which exhibits the most specific expression in myoepithelial cells, making it the optimal candidate for targeted intervention in Sjögren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and retrieve their cell‐type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with myoepithelial cell-activated genes in PINNACLE to define the cell-type–specific targets for Sjögren syndrome. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. Finally, if one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RECK', 'CST4', 'MAGEB4', 'FCGRT', 'LMO7']",Sjogren syndrome,myoepithelial cell,FCGRT,"Which gene among RECK, CST4, MAGEB4, FCGRT, and LMO7 exhibits the highest specificity for myoepithelial cells, making it the most promising candidate for targeting in Sjögren's syndrome?","Which gene among RECK, CST4, MAGEB4, FCGRT, and LMO7 exhibits the highest specificity for myoepithelial cells, making it the most promising candidate for targeting in Sjögren's syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine which of the myoepithelial cell-activated genes in PINNACLE overlap with these targets, forming a set of cell-type-specific targets for Sjogren syndrome. For this overlapping set, compute the average embedding as a reference and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SORCS3', 'PRR35', 'MIF', 'MYL2', 'TAF6L']",Sjogren syndrome,myoepithelial cell,MIF,"Among the genes SORCS3, PRR35, MIF, MYL2, and TAF6L, which exhibits the highest specificity of expression in myoepithelial cells, making it the most suitable candidate for targeted intervention in Sjögren’s syndrome?","Among the genes SORCS3, PRR35, MIF, MYL2, and TAF6L, which exhibits the highest specificity of expression in myoepithelial cells, making it the most suitable candidate for targeted intervention in Sjögren’s syndrome? Identify the verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which myoepithelial cell-activated genes from PINNACLE overlap with these targets to create a set of candidate genes. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and the embedding of each individual candidate. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SAR1A', 'ALDH7A1', 'NCOR1', 'PROSER3', 'PPIA']",Sjogren syndrome,myoepithelial cell,PPIA,"Which gene among SAR1A, ALDH7A1, NCOR1, PROSER3, and PPIA exhibits the highest cell-type-specific expression in myoepithelial cells, thereby representing the most promising target for interventions in Sjögren syndrome?","Which gene among SAR1A, ALDH7A1, NCOR1, PROSER3, and PPIA exhibits the highest cell-type-specific expression in myoepithelial cells, thereby representing the most promising target for interventions in Sjögren syndrome? Using verified therapeutic targets for Sjögren syndrome, retrieve their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the genes activated in myoepithelial cells within PINNACLE. For the overlapping gene set, calculate the average embedding and compute the cosine similarity between this average and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its relevance in the context of Sjögren syndrome."
"['AGTR2', 'CSTB', 'JAK1', 'AIP', 'ATP1B4']",Sjogren syndrome,myoepithelial cell,JAK1,"Among the genes AGTR2, CSTB, JAK1, AIP, and ATP1B4, which one exhibits the most specific expression in myoepithelial cells, making it the optimal candidate for targeted therapeutic strategies in Sjögren's syndrome?","Among the genes AGTR2, CSTB, JAK1, AIP, and ATP1B4, which one exhibits the most specific expression in myoepithelial cells, making it the optimal candidate for targeted therapeutic strategies in Sjögren's syndrome? Identify validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which myoepithelial cell–activated genes from PINNACLE overlap with these targets to define the cell-type–specific therapeutic targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target gene's embedding. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['KCNMB4', 'HLA-B', 'CMIP', 'RUBCNL', 'MRPS14']",Sjogren syndrome,myoepithelial cell,HLA-B,"Which gene—KCNMB4, HLA-B, CMIP, RUBCNL, or MRPS14—exhibits the highest cell-type specificity in myoepithelial cells for targeting Sjogren syndrome?","Which gene—KCNMB4, HLA-B, CMIP, RUBCNL, or MRPS14—exhibits the highest cell-type specificity in myoepithelial cells for targeting Sjogren syndrome? Using the PINNACLE dataset, identify validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings. Next, determine which myoepithelial cell-activated genes overlap with these targets, thereby defining a set of cell-type–specific targets for the condition. Calculate the average embedding for this gene set as a reference, and then compute the cosine similarity between this reference and each individual target gene. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['IL10RB', 'PLPP6', 'FAM50B', 'ERI1', 'FCGRT']",Sjogren syndrome,myoepithelial cell,FCGRT,"Among IL10RB, PLPP6, FAM50B, ERI1, and FCGRT, which gene exhibits the highest specificity of expression in myoepithelial cells for potential targeting in Sjögren's syndrome?","Among IL10RB, PLPP6, FAM50B, ERI1, and FCGRT, which gene exhibits the highest specificity of expression in myoepithelial cells for potential targeting in Sjögren's syndrome? Identify the validated therapeutic gene targets for Sjögren's syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Then, determine which of these targets overlap with the set of genes activated in myoepithelial cells in PINNACLE. Calculate the average embedding for this overlapping set and compute the cosine similarity between the average and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GBP5', 'EAF2', 'FKBP1A', 'THAP12', 'ZNF576']",Sjogren syndrome,myoepithelial cell,FKBP1A,"Among the genes GBP5, EAF2, FKBP1A, THAP12, and ZNF576, which exhibits the highest cell-type specificity in myoepithelial cells, making it the most promising candidate for targeting in Sjogren syndrome?","Among the genes GBP5, EAF2, FKBP1A, THAP12, and ZNF576, which exhibits the highest cell-type specificity in myoepithelial cells, making it the most promising candidate for targeting in Sjogren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the myoepithelial cell-activated genes in PINNACLE overlap with these targets and compute the average embedding for this overlapping set. Then, calculate the cosine similarity between this average embedding and each individual gene target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance in Sjogren syndrome."
"['HLA-B', 'MT-ND4', 'TMTC3', 'RAB1C', 'UBR3']",Sjogren syndrome,myoepithelial cell,HLA-B,"Which gene among HLA-B, MT-ND4, TMTC3, RAB1C, and UBR3 exhibits the highest specificity in myoepithelial cells, making it the most promising target for Sjögren's syndrome?","Which gene among HLA-B, MT-ND4, TMTC3, RAB1C, and UBR3 exhibits the highest specificity in myoepithelial cells, making it the most promising target for Sjögren's syndrome? Identify the validated therapeutic targets for Sjögren syndrome and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine which myoepithelial cell-activated genes in PINNACLE overlap with these targets. For the overlapping set, calculate the average embedding to serve as a reference, and then compute the cosine similarity between this reference and each individual gene's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DGCR8', 'ARHGAP12', 'KDM5D', 'SCGB3A2', 'FCGRT']",Sjogren syndrome,myoepithelial cell,FCGRT,"Which gene—DGCR8, ARHGAP12, KDM5D, SCGB3A2, or FCGRT—exhibits the highest cell-type specificity in myoepithelial cells and is therefore the most promising candidate for targeting Sjögren syndrome?","Which gene—DGCR8, ARHGAP12, KDM5D, SCGB3A2, or FCGRT—exhibits the highest cell-type specificity in myoepithelial cells and is therefore the most promising candidate for targeting Sjögren syndrome? For Sjogren syndrome, retrieve the verified therapeutic targets and obtain their corresponding cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and the myoepithelial cell-activated genes in PINNACLE to establish a set of cell-type–specific targets. Compute the average embedding of these overlapping genes and then calculate the cosine similarity between this average reference and each individual gene’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['HEMGN', 'FKBP1A', 'HMGN3', 'SCYL2', 'CRB3']",Sjogren syndrome,myoepithelial cell,FKBP1A,"Among HEMGN, FKBP1A, HMGN3, SCYL2, and CRB3, which gene exhibits the highest specificity for myoepithelial cells as a candidate target in Sjogren syndrome?","Among HEMGN, FKBP1A, HMGN3, SCYL2, and CRB3, which gene exhibits the highest specificity for myoepithelial cells as a candidate target in Sjogren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their corresponding cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the myoepithelial cell-activated genes in PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and each target embedding. If one gene exhibits a significantly higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['FARS2', 'TRIM24', 'E2F8', 'HUS1B', 'PPIA']",Sjogren syndrome,myoepithelial cell,PPIA,"Which gene among FARS2, TRIM24, E2F8, HUS1B, and PPIA exhibits the highest specificity in myoepithelial cells, making it the best candidate for targeting Sjogren syndrome?","Which gene among FARS2, TRIM24, E2F8, HUS1B, and PPIA exhibits the highest specificity in myoepithelial cells, making it the best candidate for targeting Sjogren syndrome? Identify the confirmed therapeutic targets for Sjogren syndrome and extract their cell-type specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in myoepithelial cells in PINNACLE to define cell-type specific targets for the syndrome. Calculate the average embedding of the overlapping genes and then compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['JAK1', 'MEP1A', 'PISD', 'GUCY1B2', 'FZD3']",Sjogren syndrome,myoepithelial cell,JAK1,"Which gene among JAK1, MEP1A, PISD, GUCY1B2, and FZD3 exhibits the highest myoepithelial cell-specific expression, thereby representing the most promising single candidate for targeting in Sjögren syndrome?","Which gene among JAK1, MEP1A, PISD, GUCY1B2, and FZD3 exhibits the highest myoepithelial cell-specific expression, thereby representing the most promising single candidate for targeting in Sjögren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the myoepithelial cell-activated genes in PINNACLE overlap with these targets, and compute the average embedding of this overlapping set. Calculate the cosine similarity between this reference embedding and each individual target's embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['COX14', 'ATP1A3', 'MIF', 'WDR97', 'TARS2']",Sjogren syndrome,myoepithelial cell,MIF,"Among the genes COX14, ATP1A3, MIF, WDR97, and TARS2, which one exhibits the highest cell-type specificity in myoepithelial cells for potential targeted interventions in Sjögren syndrome?","Among the genes COX14, ATP1A3, MIF, WDR97, and TARS2, which one exhibits the highest cell-type specificity in myoepithelial cells for potential targeted interventions in Sjögren syndrome? Using PINNACLE, identify validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings. Next, focus on myoepithelial cell-activated genes in PINNACLE and determine the overlap between these genes and the established therapeutic targets. Compute the average embedding for this overlapping gene set to serve as a reference, then calculate the cosine similarity between the reference embedding and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CHST7', 'FKBP1A', 'C22orf46', 'HLA-DRB1', 'RAE1']",Sjogren syndrome,myoepithelial cell,FKBP1A,"Which gene—CHST7, FKBP1A, C22orf46, HLA-DRB1, or RAE1—demonstrates the greatest specificity for myoepithelial cells in the context of targeting Sjögren’s syndrome?","Which gene—CHST7, FKBP1A, C22orf46, HLA-DRB1, or RAE1—demonstrates the greatest specificity for myoepithelial cells in the context of targeting Sjögren’s syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the myoepithelial cell-activated genes available in PINNACLE. Calculate the average embedding for the overlapping genes and assess the cosine similarity between this reference and each individual overlapping target. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['EIF4G2', 'PPIA', 'STAC', 'HCRTR2', 'STK38L']",Sjogren syndrome,myoepithelial cell,PPIA,"Among the genes EIF4G2, PPIA, STAC, HCRTR2, and STK38L, which one exhibits the highest cell-type specificity in myoepithelial cells for targeting Sjogren syndrome?","Among the genes EIF4G2, PPIA, STAC, HCRTR2, and STK38L, which one exhibits the highest cell-type specificity in myoepithelial cells for targeting Sjogren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in myoepithelial cells to define the cell-type specificity. Calculate the average embedding for this overlapping set, then compute the cosine similarity between this average and each individual target embedding. If one gene shows a clearly higher similarity than all others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['STAT1', 'MC1R', 'UPP1', 'PALMD', 'PRMT5']",Sjogren syndrome,fibroblast,STAT1,"Among STAT1, MC1R, UPP1, PALMD, and PRMT5, which gene shows the highest fibroblast-specific expression to serve as the best candidate target for Sjögren syndrome?","Among STAT1, MC1R, UPP1, PALMD, and PRMT5, which gene shows the highest fibroblast-specific expression to serve as the best candidate target for Sjögren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and fibroblast-activated genes within PINNACLE, resulting in a set of cell-type–specific targets for Sjögren syndrome. Calculate the average embedding for this overlapping set, then compute the cosine similarity between this reference and each individual target gene. If one gene displays a substantially higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NR3C1', 'FAM153CP', 'NUDT22', 'C1GALT1C1', 'ARL6IP6']",Sjogren syndrome,fibroblast,NR3C1,"Among the genes NR3C1, FAM153CP, NUDT22, C1GALT1C1, and ARL6IP6, which one exhibits the highest fibroblast-specific expression, indicating its potential as the most suitable candidate for targeted intervention in Sjögren syndrome?","Among the genes NR3C1, FAM153CP, NUDT22, C1GALT1C1, and ARL6IP6, which one exhibits the highest fibroblast-specific expression, indicating its potential as the most suitable candidate for targeted intervention in Sjögren syndrome? Identify the validated therapeutic targets for Sjögren’s syndrome by retrieving their cell-type–specific embeddings from the PINNACLE database. Then, determine which fibroblast‐activated genes in PINNACLE overlap with these targets to form a set of cell-type–specific therapeutic candidates. Calculate the average embedding for these overlapping genes and compute the cosine similarity between this reference vector and the embedding of each candidate. If one gene exhibits markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BAZ2A', 'ZNF134', 'RAG1', 'CSF2RB', 'WDR59']",Sjogren syndrome,fibroblast,BAZ2A,"Among the genes BAZ2A, ZNF134, RAG1, CSF2RB, and WDR59, which exhibits the highest fibroblast-specific expression relevant to targeting Sjögren syndrome?","Among the genes BAZ2A, ZNF134, RAG1, CSF2RB, and WDR59, which exhibits the highest fibroblast-specific expression relevant to targeting Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the fibroblast-activated genes in PINNACLE and compute the average embedding of this overlapping set as a reference. Finally, calculate the cosine similarity between this reference embedding and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FKBP1A', 'PTPN3', 'NDUFB11', 'KLHL38', 'FFAR3']",Sjogren syndrome,fibroblast,FKBP1A,"Among FKBP1A, PTPN3, NDUFB11, KLHL38, and FFAR3, which gene shows the highest fibroblast-specific expression relevant to Sjogren syndrome, making it the most promising candidate for targeted intervention?","Among FKBP1A, PTPN3, NDUFB11, KLHL38, and FFAR3, which gene shows the highest fibroblast-specific expression relevant to Sjogren syndrome, making it the most promising candidate for targeted intervention? Identify verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these therapeutic targets and the fibroblast-activated genes in PINNACLE. Compute the average embedding for this overlapping set as a reference, and calculate the cosine similarity between the reference embedding and each individual target’s embedding. If one target consistently shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LDOC1', 'PDIA4', 'SYNE4', 'SREBF1', 'SMARCC2']",Sjogren syndrome,fibroblast,SMARCC2,"Among the genes LDOC1, PDIA4, SYNE4, SREBF1, and SMARCC2, which one exhibits the highest fibroblast-specific expression relevant for potential therapeutic targeting in Sjögren's syndrome?","Among the genes LDOC1, PDIA4, SYNE4, SREBF1, and SMARCC2, which one exhibits the highest fibroblast-specific expression relevant for potential therapeutic targeting in Sjögren's syndrome? Identify the validated therapeutic gene targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the fibroblast-activated genes in PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this average and each individual gene target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['JAK1', 'ZNF835', 'PLEKHG6', 'TCF3', 'ANKRD28']",Sjogren syndrome,fibroblast,JAK1,"Among the genes JAK1, ZNF835, PLEKHG6, TCF3, and ANKRD28, which one shows the highest fibroblast cell-type specificity, making it the most promising candidate for targeted intervention in Sjögren's syndrome?","Among the genes JAK1, ZNF835, PLEKHG6, TCF3, and ANKRD28, which one shows the highest fibroblast cell-type specificity, making it the most promising candidate for targeted intervention in Sjögren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the fibroblast-activated genes in PINNACLE to define the cell-type–specific targets for Sjögren syndrome. Calculate the average embedding of this overlapping set as a reference vector, and then assess the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['ADAT3', 'SCG2', 'ACY3', 'SERTAD4', 'HLA-B']",Sjogren syndrome,fibroblast,HLA-B,"Which gene among ADAT3, SCG2, ACY3, SERTAD4, and HLA-B exhibits the highest fibroblast cell-type specificity for targeting Sjögren syndrome?","Which gene among ADAT3, SCG2, ACY3, SERTAD4, and HLA-B exhibits the highest fibroblast cell-type specificity for targeting Sjögren syndrome? Identify validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with fibroblast-activated genes in PINNACLE. For the overlapping set, compute an average embedding and calculate the cosine similarity between this average and each individual target. If one gene shows considerably higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance in Sjogren syndrome."
"['GSTA4', 'PPIA', 'UQCR10', 'MYLK', 'EEF1A1P5']",Sjogren syndrome,fibroblast,PPIA,"Which gene—GSTA4, PPIA, UQCR10, MYLK, or EEF1A1P5—exhibits the highest fibroblast-specificity for potential therapeutic targeting in Sjögren's syndrome?","Which gene—GSTA4, PPIA, UQCR10, MYLK, or EEF1A1P5—exhibits the highest fibroblast-specificity for potential therapeutic targeting in Sjögren's syndrome? Identify validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the set of fibroblast-activated genes in PINNACLE, defining these as the cell-type–specific targets for Sjogren syndrome. Compute the average embedding for this overlapping set, and then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DDX6', 'TYW1', 'GNAL', 'PLCG1', 'XAGE3']",Sjogren syndrome,fibroblast,DDX6,"Which gene among DDX6, TYW1, GNAL, PLCG1, and XAGE3 demonstrates the highest fibroblast-specific expression, making it the most promising candidate target for Sjogren syndrome?","Which gene among DDX6, TYW1, GNAL, PLCG1, and XAGE3 demonstrates the highest fibroblast-specific expression, making it the most promising candidate target for Sjogren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the fibroblast-activated genes available in PINNACLE overlap with these targets to define the cell-type–specific targets for Sjogren syndrome. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this average reference and the embedding of each individual target. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NR2C2', 'FADS3', 'LGALS8', 'IFNAR1', 'XIRP2']",Sjogren syndrome,fibroblast,IFNAR1,"Among NR2C2, FADS3, LGALS8, IFNAR1, and XIRP2, which gene exhibits the most fibroblast-specific expression and would therefore be the most promising candidate for targeting Sjögren syndrome?","Among NR2C2, FADS3, LGALS8, IFNAR1, and XIRP2, which gene exhibits the most fibroblast-specific expression and would therefore be the most promising candidate for targeting Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which fibroblast-activated genes in PINNACLE overlap with these targets to compile a set of cell-type–specific targets. Compute the average embedding for this set and evaluate the cosine similarity between this reference embedding and each individual target's embedding. If one gene exhibits significantly higher similarity than the rest, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF250', 'IFT172', 'HMBS', 'FMR1', 'RCN1']",Sjogren syndrome,fibroblast,RCN1,"Which gene among ZNF250, IFT172, HMBS, FMR1, and RCN1 demonstrates the highest fibroblast-specific expression for targeting Sjögren syndrome?","Which gene among ZNF250, IFT172, HMBS, FMR1, and RCN1 demonstrates the highest fibroblast-specific expression for targeting Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the fibroblast-activated genes in PINNACLE. For this overlapping set, compute the average embedding and then calculate the cosine similarity between this average and each individual gene’s embedding. If one gene exhibits a markedly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GTF2I', 'USP25', 'SLC43A2', 'CDK2AP1', 'GTPBP3']",Sjogren syndrome,fibroblast,GTF2I,"Among the candidate genes (GTF2I, USP25, SLC43A2, CDK2AP1, GTPBP3), which one exhibits the greatest fibroblast-specific expression in the context of targeting Sjögren's syndrome?","Among the candidate genes (GTF2I, USP25, SLC43A2, CDK2AP1, GTPBP3), which one exhibits the greatest fibroblast-specific expression in the context of targeting Sjögren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the PINNACLE-defined fibroblast-activated genes, as this intersection represents the cell-type–specific targets for Sjögren syndrome. For these overlapping genes, compute an average embedding as a reference, and then calculate the cosine similarity of each gene's embedding relative to this reference. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['GIMAP5', 'NUTF2', 'VWA5A', 'BCL2L14', 'HLA-DRA']",Sjogren syndrome,fibroblast,HLA-DRA,"Which gene—GIMAP5, NUTF2, VWA5A, BCL2L14, or HLA-DRA—exhibits the most specific expression in fibroblasts, making it the best candidate for targeting in Sjogren's syndrome?","Which gene—GIMAP5, NUTF2, VWA5A, BCL2L14, or HLA-DRA—exhibits the most specific expression in fibroblasts, making it the best candidate for targeting in Sjogren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome from PINNACLE and extract their corresponding cell-type–specific embeddings. Next, determine the subset of these targets that overlaps with the fibroblast-activated genes in PINNACLE. For this overlapping set, compute the average embedding as a reference and then calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene exhibits a notably higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['SGCE', 'ICE2', 'RCN1', 'CIB4', 'TKT']",Sjogren syndrome,fibroblast,RCN1,"Which gene out of SGCE, ICE2, RCN1, CIB4, and TKT exhibits the most fibroblast-specific expression for potential targeting in Sjogren syndrome?","Which gene out of SGCE, ICE2, RCN1, CIB4, and TKT exhibits the most fibroblast-specific expression for potential targeting in Sjogren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which fibroblast-activated genes in PINNACLE overlap with these targets to create a set of cell-type–specific targets. Compute the average embedding for this overlap, then calculate the cosine similarity between this average vector and the embedding of each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ANXA13', 'DNPH1', 'THAP4', 'MAN2A1', 'BAZ2A']",Sjogren syndrome,fibroblast,BAZ2A,"Which gene among ANXA13, DNPH1, THAP4, MAN2A1, and BAZ2A exhibits the highest fibroblast-specific expression relevant for targeting Sjögren’s syndrome?","Which gene among ANXA13, DNPH1, THAP4, MAN2A1, and BAZ2A exhibits the highest fibroblast-specific expression relevant for targeting Sjögren’s syndrome? Identify validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of fibroblast-activated genes in PINNACLE. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF695', 'MUC6', 'TNK2', 'SNTG2', 'IFNAR1']",Sjogren syndrome,fibroblast,IFNAR1,"Among the genes ZNF695, MUC6, TNK2, SNTG2, and IFNAR1, which exhibits the highest fibroblast-specific expression relevant to targeting Sjogren syndrome?","Among the genes ZNF695, MUC6, TNK2, SNTG2, and IFNAR1, which exhibits the highest fibroblast-specific expression relevant to targeting Sjogren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from the PINNACLE database. Determine the subset of these targets that overlaps with the fibroblast-activated genes in PINNACLE. For this overlapping set, compute an average embedding as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MYH15', 'PPIA', 'VMA21', 'NEK11', 'NTAN1']",Sjogren syndrome,fibroblast,PPIA,"Among the genes MYH15, PPIA, VMA21, NEK11, and NTAN1, which shows the highest fibroblast-specific expression and thus represents the most promising candidate for targeting Sjögren's syndrome?","Among the genes MYH15, PPIA, VMA21, NEK11, and NTAN1, which shows the highest fibroblast-specific expression and thus represents the most promising candidate for targeting Sjögren's syndrome? Using the curated list of validated therapeutic targets for Sjogren syndrome, retrieve their cell-type–specific embeddings from the PINNACLE dataset. Identify which of these targets overlap with PINNACLE’s fibroblast-activated genes and compute the average embedding of the overlapping set. Then, calculate the cosine similarity between this average embedding and the embedding of each overlapping gene. If one gene exhibits a markedly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance in Sjogren syndrome."
"['DRP2', 'ATG16L2', 'GTF2I', 'OR5H1', 'TEX47']",Sjogren syndrome,fibroblast,GTF2I,"Which gene among DRP2, ATG16L2, GTF2I, OR5H1, and TEX47 exhibits the highest fibroblast-specific expression, indicating its potential as the most promising target for Sjogren syndrome intervention?","Which gene among DRP2, ATG16L2, GTF2I, OR5H1, and TEX47 exhibits the highest fibroblast-specific expression, indicating its potential as the most promising target for Sjogren syndrome intervention? Identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with fibroblast-activated genes in the dataset. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['THBS2', 'COPG2', 'STAT1', 'SPDEF', 'PIGG']",Sjogren syndrome,fibroblast,STAT1,"Which gene among THBS2, COPG2, STAT1, SPDEF, and PIGG shows the most fibroblast-specific expression, making it the most promising candidate for targeted intervention in Sjögren syndrome?","Which gene among THBS2, COPG2, STAT1, SPDEF, and PIGG shows the most fibroblast-specific expression, making it the most promising candidate for targeted intervention in Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and extract their corresponding cell-type–specific embeddings from PINNACLE. Then, identify which fibroblast-activated genes reported in PINNACLE overlap with these targets. For this overlapping set, calculate the average embedding and compute the cosine similarity between this reference and the embedding of each individual target gene. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-supported rationale for its biological relevance."
"['JAK1', 'TET1', 'ZNF689', 'TASOR', 'UTP11']",Sjogren syndrome,fibroblast,JAK1,"Among the genes JAK1, TET1, ZNF689, TASOR, and UTP11, which one shows the highest fibroblast cell-type specificity in relation to Sjogren syndrome?","Among the genes JAK1, TET1, ZNF689, TASOR, and UTP11, which one shows the highest fibroblast cell-type specificity in relation to Sjogren syndrome? Identify experimentally validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, identify which of the fibroblast-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for Sjögren syndrome. Compute the average embedding for this overlapping set, then calculate the cosine similarity between the average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
